- Home
- LDP vs GRAL Comparison
LDP vs GRAL Comparison
Compare LDP & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDP
- GRAL
- Stock Information
- Founded
- LDP 2012
- GRAL 2016
- Country
- LDP United States
- GRAL United States
- Employees
- LDP N/A
- GRAL N/A
- Industry
- LDP Finance Companies
- GRAL
- Sector
- LDP Finance
- GRAL
- Exchange
- LDP Nasdaq
- GRAL NYSE
- Market Cap
- LDP 556.9M
- GRAL 1.3B
- IPO Year
- LDP N/A
- GRAL N/A
- Fundamental
- Price
- LDP $21.21
- GRAL $46.87
- Analyst Decision
- LDP
- GRAL Buy
- Analyst Count
- LDP 0
- GRAL 3
- Target Price
- LDP N/A
- GRAL $31.50
- AVG Volume (30 Days)
- LDP 102.5K
- GRAL 1.6M
- Earning Date
- LDP 01-01-0001
- GRAL 08-12-2025
- Dividend Yield
- LDP 7.91%
- GRAL N/A
- EPS Growth
- LDP N/A
- GRAL N/A
- EPS
- LDP N/A
- GRAL N/A
- Revenue
- LDP N/A
- GRAL $130,711,000.00
- Revenue This Year
- LDP N/A
- GRAL $19.52
- Revenue Next Year
- LDP N/A
- GRAL $20.37
- P/E Ratio
- LDP N/A
- GRAL N/A
- Revenue Growth
- LDP N/A
- GRAL 30.47
- 52 Week Low
- LDP $16.16
- GRAL $12.33
- 52 Week High
- LDP $20.30
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- LDP 75.87
- GRAL N/A
- Support Level
- LDP $20.85
- GRAL N/A
- Resistance Level
- LDP $21.25
- GRAL N/A
- Average True Range (ATR)
- LDP 0.13
- GRAL 0.00
- MACD
- LDP 0.03
- GRAL 0.00
- Stochastic Oscillator
- LDP 93.42
- GRAL 0.00
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.